Raleigh Startup Scioderm Nets $9 Million  
4/30/2013 8:59:35 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Raleigh startup Scioderm has nabbed $9 million in equity in a recent fundraise. A newly released securities filing shows that the team still has $7 million to go in the round. The dermatological research firm aims to in-license or acquire pharmaceuticals to develop topical products. Its lead candidate, SD-101, aims to treat Epidermolysis Bullosa (EB), an inherited disease that causes painful blisters.

Help employers find you! Check out all the jobs and post your resume.